Skip to content

Study on the Effect of Homoeopathic Treatment in Women Suffering from Cystitis During Perimenopausal Period

Application of Murphys repertory in homoeopathic treatment of cystitis in perimenopausal women: randomized uncontrolled clinical trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107116
Enrollment
40
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N309- Cystitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Treatment using Murphys Repertory: Women diagnosed with cystitis in the perimenopausal period will receive individualized homoeopathic medicines selected usi

Sponsors

Dr Dipika Bhagwat Andhale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged 40 60 years . 2. Diagnosed cases of acute or recurrent cystitis. 3. Willing to take only homeopathic treatment during study. 4. Able to give informed consent. 5. Suitable for individualized homeopathic treatment. 6. Ready to attend follow-ups regularly

Exclusion criteria

Exclusion criteria: 1. Women below 40 or above 60 years of age. 2. Pregnant or lactating women. 3. Cystitis due to structural abnormalities or kidney diseases. 4. Patients with serious systemic illnesses (e.g., diabetes with complications, renal failure, cancer). 5. Those undergoing antibiotic or allopathic treatment during the study. 6. Mentally or cognitively impaired individuals unable to consent. 7. Women with catheter-associated or hospital-acquired UTIs.

Design outcomes

Primary

MeasureTime frame
Reduction in the severity and frequency of cystitis symptoms (dysuria, urinary frequency, urgency, burning sensation, and suprapubic discomfort) from baseline to the end of the treatment period, measured using a standardized symptom scoring scale (e.g., 0 10 Visual Analogue Scale for each symptom or Acute Cystitis Symptom Score) at scheduled follow-up visits.Timepoint: Baseline (Day 0), followed by assessments at 2 weeks, 4 weeks, 8 weeks, and 12 weeks (end of 3-month treatment period). Patients will be advised to report symptoms at each scheduled follow-up visit and any worsening of symptoms in between visits

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Dipika Bhagwat Andhale

Sonajirao Kshirsagar Homoeopathic Medical College, Beed

drkulkarniajay@gmail.com9422243446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026